Auristatin peptide analogs of MeVal-Val-Dil-Dap-Phe (MMAF) having a carboxylic acid equivalent at the C-terminal phenylalanine were prepared and attached to ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.
具有C-末端苯丙
氨酸羧基酸等效物的MeVal-Val-Dil-Dap-Phe(
MMAF)的Auristatin肽类类似物已经制备,并通过各种连接剂(包括maleimidocaproyl-val-cit-PAB)连接到
配体上。 结果得到的
配体药物结合物在体外和体内均具有活性。